BioJapan (held alongside Regenerative Medicine Japan) will celebrate its 20th anniversary in 2018. The event has been a critical platform for industry and academic experts in the drug discovery, personalised medicine, regenerative medicine and diagnostics sectors. In 2017, BioJapan had 900+ exhibitors and attracted 15,000+ visitors to the conference which is regarded as the biggest international conference in this field in Asia.
Austrade will coordinate Australia’s presence at BioJapan 2018. In conjunction with AusBiotech, the Australian Government aims to increase awareness of Australia’s Life Sciences sector, high quality research capabilities, and position Australia’s biotech expertise to Japanese and international audiences. The aim is to enhance further collaboration between Australia and Japanese life sciences and medical research communities.
Our involvement is sponsored by DFAT’s Australia now program to showcase Australia in Japan in 2018.